ClinicalTrials.Veeva

Menu

Clinical Impact of Non-invasive Neurally Adjusted Ventilatory Assist in Very Preterm Infants

K

Korea University

Status

Enrolling

Conditions

Preterm Infant

Treatments

Procedure: Non-invasive NAVA

Study type

Observational

Funder types

Other

Identifiers

NCT06786039
2024AN0554

Details and patient eligibility

About

This is a prospective observational study investigating the impact of NIV-NAVA on short-term clinical outcomes and long-term neurodevelopment in very preterm infants.

Enrollment

80 estimated patients

Sex

All

Ages

1 to 48 hours old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Preterm infants born between 27 weeks 0 days to 31 weeks 6 days of gestation
  • Preterm infants who require respiratory support within the first 48 hours of life

Exclusion criteria

  • Preterm infants who die within the first 48 hours of life
  • Preterm infants who do not require any respiratory support within the first 48 hours of life.
  • Preterm infants with congenital anomalies affecting the lungs, heart, or other organs that could influence breathing
  • Infants whose parents do not consent to participate in the study

Trial design

80 participants in 1 patient group

NIV-NAVA application
Description:
Preterm infants born between 27 weeks 0 days to 31 weeks 6 days of gestation requiring respiratory support within 48 hours after birth
Treatment:
Procedure: Non-invasive NAVA

Trial contacts and locations

2

Loading...

Central trial contact

Hannah Cho, Professor; Juyoung Lee, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems